Crystalys Therapeutics Launches With $205 Million Series A Financing to Advance Gout Treatment

Leila Ahmed
Tagged:

Latham & Watkins has advised Crystalys Therapeutics. Wilson Sonsini Goodrich & Rosati has advised Novo Holdings and SR One.Crystalys Therapeutics Inc., a clinical-stage biopharmaceutical company, has…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Author: Leila Ahmed

…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here